e-learning
resources
Vienna 2012
Wednesday, 05.09.2012
Severe asthma and developing allergy in childhood
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Fungal sensitisation in children with severe therapy resistant asthma
M. Maglione, S. Castanhinha, A. Gupta, S. Koo, C. Bossley, L. Fleming, A. Bush, S. Saglani (London, United Kingdom; Lisbon, Portugal; Naples, Italy; Hong Kong, China)
Source:
Annual Congress 2012 - Severe asthma and developing allergy in childhood
Session:
Severe asthma and developing allergy in childhood
Session type:
Oral Presentation
Number:
4711
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Maglione, S. Castanhinha, A. Gupta, S. Koo, C. Bossley, L. Fleming, A. Bush, S. Saglani (London, United Kingdom; Lisbon, Portugal; Naples, Italy; Hong Kong, China). Fungal sensitisation in children with severe therapy resistant asthma. Eur Respir J 2012; 40: Suppl. 56, 4711
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Is fungal sensitisation associated with exacerbation-prone or severe preschool wheezing?
Source: International Congress 2019 – Severe acute asthma and troublesome wheezing
Year: 2019
Anti-IgE treatment in children with severe intrinsic asthma
Source: International Congress 2019 – Severe acute asthma and troublesome wheezing
Year: 2019
Prevalence of therapeutic resistant and steroid resistant bronchial asthma in children and adolescents
Source: Eur Respir J 2005; 26: Suppl. 49, 681s
Year: 2005
Novel therapies for severe asthma in children and adults
Source: Breathe, 14 (1) 59; 10.1183/20734735.018917
Year: 2018
The impact of targeted therapy in children with uncontrolled allergic persistent severe asthma and nasal polyps
Source: International Congress 2017 – Paediatric asthma: therapies and comorbidities
Year: 2017
Omalizumab is an effective intervention in severe asthma with aspergillus sensitisation.
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020
Immunotherapy in severe asthma
Source: ERS webinar 2021: Immunotherapy in severe asthma
Year: 2021
Severe asthma in children
Source: CME Online 2011
Year: 2011
Severe asthma in children
Source: International Congress 2015 – Fingerprinting severe asthma
Year: 2015
Aspergillus sensitization and aspergillus-associated diseases in a sample of patients with severe asthma
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019
Management of difficult-to-treat severe asthma
Source: Eur Respir Mon 2011; 51: 282-296
Year: 2011
Omalizumab treatment reduces asthma exacerbations in children with moderate or severe persistent asthma
Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues
Year: 2017
Omalizumab in children with severe persistent allergic asthma
Source: Annual Congress 2010 - Managing asthma and allergic disease in children
Year: 2010
Management of severe asthma in children
Source: Annual Congress 2010 - ERS/[italic]Lancet[/italic] Asthma
Year: 2010
ME11 Management of severe asthma in children
Source: Paris 2018 - Educational material
Year: 2018
Management of severe asthma in children
Source: Virtual Congress 2020 – Reducing the burden of asthma
Year: 2020
Management of severe asthma in children
Source: International Congress 2018 – ME11 Management of severe asthma in children FULLY BOOKED
Year: 2018
Role of atypical bacterial infections in exacerbation of asthma in children
Source: Eur Respir J 2005; 26: Suppl. 49, 165s
Year: 2005
Small airways targeting of inhaled steroids for severe therapy resistant asthma in children
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015
Improvement in asthma severity and control by voriconazole and posaconazole in severe asthma with fungal sensitization (SAFS) and ABPA
Source: Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept